Evidence map›Paper›PMID 32178768›Full record

ArticleLancet (London, England)2020

First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.

Isaac Ghinai, Tristan D McPherson, Jennifer C Hunter, Hannah L Kirking, Demian Christiansen, Kiran Joshi, Rachel Rubin, Shirley Morales-Estrada, Stephanie R Black, Massimo Pacilli and 29 more

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05175716 (Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room), which is not on this map. Cited by 275 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05175716 completednot on this mapstarted 2022, after this paper: background citation

Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2022 to 2022Enrolled2,447ConditionsCOVID-19, Labor
3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

Isaac GhinaiEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Illinois Department of Public Health, Springfield, IL, USA.
Tristan D McPhersonEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Chicago Department of Public Health, Chicago, IL, USA. Electronic address: oko9@cdc.gov.
Jennifer C HunterDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hannah L KirkingDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Demian ChristiansenCook County Department of Public Health, Oak Forest, IL, USA.
Kiran JoshiCook County Department of Public Health, Oak Forest, IL, USA.
Rachel RubinCook County Department of Public Health, Oak Forest, IL, USA.
Shirley Morales-EstradaCook County Department of Public Health, Oak Forest, IL, USA.
Stephanie R BlackChicago Department of Public Health, Chicago, IL, USA.
Massimo PacilliChicago Department of Public Health, Chicago, IL, USA.
Marielle J FricchioneChicago Department of Public Health, Chicago, IL, USA.
Rashmi K ChughDuPage County Health Department, Wheaton, IL, USA.
Kelly A WalblayChicago Department of Public Health, Chicago, IL, USA.
N Seema AhmedMetro Infectious Disease Consultants, Burr Ridge, IL, USA.
William C StoeckerMetro Infectious Disease Consultants, Burr Ridge, IL, USA.
Nausheen F HasanPremier Primary Care Physicians, Carol Stream, IL, USA.
Deborah P BurdsallIllinois Department of Public Health, Springfield, IL, USA.
Heather E ReeseEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Megan WallaceEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Chen WangCook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Darcie MoellerCook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Jacqueline KorpicsCook County Health, Chicago, IL, USA; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Shannon A NovosadDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Isaac BenowitzDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Max W JacobsInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
Vishal S DasariOne Health Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
Megan T PatelIllinois Department of Public Health, Springfield, IL, USA.
Judy KaueraufIllinois Department of Public Health, Springfield, IL, USA.
E Matt CharlesIllinois Department of Public Health, Springfield, IL, USA.
Ngozi O EzikeIllinois Department of Public Health, Springfield, IL, USA.
Victoria ChuEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Claire M MidgleyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Melissa A RolfesInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Xiaoyan LuDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Stephen LindstromDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jennifer R VeraniDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jennifer E LaydenChicago Department of Public Health, Chicago, IL, USA. Electronic address: jennifer.layden@cityofchicago.org.
Illinois COVID-19 Investigation Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA.

methodsPatients with confirmed COVID-19 were defined as those with a positive SARS-CoV-2 test. Contacts were people with exposure to a patient with COVID-19 on or after the patient's symptom onset date. Contacts underwent active symptom monitoring for 14 days following their last exposure. Contacts who developed fever, cough, or shortness of breath became persons under investigation and were tested for SARS-CoV-2. A convenience sample of 32 asymptomatic health-care personnel contacts were also tested.

findingsPatient 1-a woman in her 60s-returned from China in mid-January, 2020. One week later, she was hospitalised with pneumonia and tested positive for SARS-CoV-2. Her husband (Patient 2) did not travel but had frequent close contact with his wife. He was admitted 8 days later and tested positive for SARS-CoV-2. Overall, 372 contacts of both cases were identified; 347 underwent active symptom monitoring, including 152 community contacts and 195 health-care personnel. Of monitored contacts, 43 became persons under investigation, in addition to Patient 2. These 43 persons under investigation and all 32 asymptomatic health-care personnel tested negative for SARS-CoV-2.

interpretationPerson-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while Patient 1 was symptomatic. Despite active symptom monitoring and testing of symptomatic and some asymptomatic contacts, no further transmission was detected.

fundingNone.

Indexed as

BetacoronavirusChinaContact TracingCoronavirus InfectionsCOVID-19FemaleHumansIllinoisMiddle AgedPandemicsPneumonia, ViralSARS-CoV-2Travel

Identifiers

PMID32178768
PMCPMC7158585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.